Brain/physiopathology; Brain Mapping/methods; Humans; Neurodegenerative Diseases/genetics; Protein Aggregates/genetics; Protein Interaction Mapping/methods; ARF-GEP(100); PPI validation; TDP-43; aggregation modulators; disease network modules; disease-causing proteins; neurodegenerative diseases; protein aggregation; protein-protein interactions; yeast-two-hybrid
Abstract :
[en] Interactome maps are valuable resources to elucidate protein function and disease mechanisms. Here, we report on an interactome map that focuses on neurodegenerative disease (ND), connects ∼5,000 human proteins via ∼30,000 candidate interactions and is generated by systematic yeast two-hybrid interaction screening of ∼500 ND-related proteins and integration of literature interactions. This network reveals interconnectivity across diseases and links many known ND-causing proteins, such as α-synuclein, TDP-43, and ATXN1, to a host of proteins previously unrelated to NDs. It facilitates the identification of interacting proteins that significantly influence mutant TDP-43 and HTT toxicity in transgenic flies, as well as of ARF-GEP(100) that controls misfolding and aggregation of multiple ND-causing proteins in experimental model systems. Furthermore, it enables the prediction of ND-specific subnetworks and the identification of proteins, such as ATXN1 and MKL1, that are abnormally aggregated in postmortem brains of Alzheimer's disease patients, suggesting widespread protein aggregation in NDs.
Amberger, J.S., Bocchini, C.A., Schiettecatte, F., Scott, A.F., Hamosh, A., OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 43 (2015), D789–D798.
Archbold, H.C., Jackson, K.L., Arora, A., Weskamp, K., Tank, E.M., Li, X., Miguez, R., Dayton, R.D., Tamir, S., Klein, R.L., Barmada, S.J., TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep., 8, 2018, 4606.
Arumughan, A., Roske, Y., Barth, C., Forero, L.L., Bravo-Rodriguez, K., Redel, A., Kostova, S., McShane, E., Opitz, R., Faelber, K., et al. Quantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamers. Nat. Commun., 7, 2016, 13047.
Assenov, Y., Ramirez, F., Schelhorn, S.E., Lengauer, T., Albrecht, M., Computing topological parameters of biological networks. Bioinformatics 24 (2008), 282–284.
Bando, Y., Onuki, R., Katayama, T., Manabe, T., Kudo, T., Taira, K., Tohyama, M., Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem. Int. 46 (2005), 11–18.
Barabási, A.L., Gulbahce, N., Loscalzo, J., Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12 (2011), 56–68.
Bawa, P., Pradeep, P., Kumar, P., Choonara, Y.E., Modi, G., Pillay, V., Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. Drug Discov. Today 21 (2016), 1886–1914.
Braun, P., Tasan, M., Dreze, M., Barrios-Rodiles, M., Lemmens, I., Yu, H., Sahalie, J.M., Murray, R.R., Roncari, L., de Smet, A.S., et al. An experimentally derived confidence score for binary protein-protein interactions. Nat. Methods 6 (2009), 91–97.
Brehme, M., Voisine, C., Rolland, T., Wachi, S., Soper, J.H., Zhu, Y., Orton, K., Villella, A., Garza, D., Vidal, M., et al. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep. 9 (2014), 1135–1150.
Brettschneider, J., Del Tredici, K., Lee, V.M., Trojanowski, J.Q., Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat. Rev. Neurosci. 16 (2015), 109–120.
Chaurasia, G., Iqbal, Y., Haenig, C., Herzel, H., Wanker, E.E., Futschik, M.E., UniHI: an entry gate to the human protein interactome. Nucleic Acids Res. 35 (2007), D590–D594.
Chen, X., Burgoyne, R.D., Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms. BMC Genomics, 13, 2012, 71.
Chen-Plotkin, A.S., Lee, V.M., Trojanowski, J.Q., TAR DNA-binding protein 43 in neurodegenerative disease. Nat. Rev. Neurol. 6 (2010), 211–220.
Chiti, F., Dobson, C.M., Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006), 333–366.
Ciryam, P., Tartaglia, G.G., Morimoto, R.I., Dobson, C.M., Vendruscolo, M., Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins. Cell Rep. 5 (2013), 781–790.
Ciryam, P., Kundra, R., Morimoto, R.I., Dobson, C.M., Vendruscolo, M., Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases. Trends Pharmacol. Sci. 36 (2015), 72–77.
Conforti, F.L., Spataro, R., Sproviero, W., Mazzei, R., Cavalcanti, F., Condino, F., Simone, I.L., Logroscino, G., Patitucci, A., Magariello, A., et al. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology 79 (2012), 2315–2320.
Cowen, L., Ideker, T., Raphael, B.J., Sharan, R., Network propagation: a universal amplifier of genetic associations. Nat. Rev. Genet. 18 (2017), 551–562.
Dietzl, G., Chen, D., Schnorrer, F., Su, K.C., Barinova, Y., Fellner, M., Gasser, B., Kinsey, K., Oppel, S., Scheiblauer, S., et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448 (2007), 151–156.
Ehrnhoefer, D.E., Wong, B.K., Hayden, M.R., Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. Nat. Rev. Drug Discov. 10 (2011), 853–867.
Elion, E.A., Detection of protein-protein interactions by coprecipitation. Curr. Protoc. Mol. Biol., 76, 2006 20.5.1–20.5.10.
Feuillette, S., Deramecourt, V., Laquerriere, A., Duyckaerts, C., Delisle, M.B., Maurage, C.A., Blum, D., Buée, L., Frébourg, T., Campion, D., Lecourtois, M., Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains. Brain Res. 1345 (2010), 182–189.
Fontaine, J.F., Barbosa-Silva, A., Schaefer, M., Huska, M.R., Muro, E.M., Andrade-Navarro, M.A., MedlineRanker: flexible ranking of biomedical literature. Nucleic Acids Res. 37 (2009), W141–W146.
Fontaine, J.F., Priller, F., Barbosa-Silva, A., Andrade-Navarro, M.A., Génie: literature-based gene prioritization at multi genomic scale. Nucleic Acids Res. 39 (2011), W455–W461.
Freibaum, B.D., Chitta, R.K., High, A.A., Taylor, J.P., Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res. 9 (2010), 1104–1120.
Gatchel, J.R., Zoghbi, H.Y., Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6 (2005), 743–755.
Gidalevitz, T., Ben-Zvi, A., Ho, K.H., Brignull, H.R., Morimoto, R.I., Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 311 (2006), 1471–1474.
Goedert, M., NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein. Science, 349, 2015, 1255555.
Goehler, H., Lalowski, M., Stelzl, U., Waelter, S., Stroedicke, M., Worm, U., Droege, A., Lindenberg, K.S., Knoblich, M., Haenig, C., et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol. Cell 15 (2004), 853–865.
Gottlieb, A., Magger, O., Berman, I., Ruppin, E., Sharan, R., PRINCIPLE: a tool for associating genes with diseases via network propagation. Bioinformatics 27 (2011), 3325–3326.
Gratuze, M., Cisbani, G., Cicchetti, F., Planel, E., Is Huntington's disease a tauopathy?. Brain 139 (2016), 1014–1025.
Grünberg, R., Burnier, J.V., Ferrar, T., Beltran-Sastre, V., Stricher, F., Van Der Sloot, A.M., Garcia-Olivas, R., Mallabiabarrena, A., Sanjuan, X., Zimmermann, T., et al. Engineering of weak helper interactions for high-efficiency FRET probes. Nat. Methods 10 (2013), 1021–1027.
Hein, M.Y., Hubner, N.C., Poser, I., Cox, J., Nagaraj, N., Toyoda, Y., Gak, I.A., Weisswange, I., Mansfeld, J., Buchholz, F., et al. A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 163 (2015), 712–723.
Higashi, S., Iseki, E., Yamamoto, R., Minegishi, M., Hino, H., Fujisawa, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., et al. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res. 1184 (2007), 284–294.
Hosp, F., Vossfeldt, H., Heinig, M., Vasiljevic, D., Arumughan, A., Wyler, E., Landthaler, M., Hubner, N., Wanker, E.E., Lannfelt, L., et al., Genetic and Environmental Risk for Alzheimer's Disease GERAD1 Consortium. Quantitative interaction proteomics of neurodegenerative disease proteins. Cell Rep. 11 (2015), 1134–1146.
Hugon, J., Mouton-Liger, F., Dumurgier, J., Paquet, C., PKR involvement in Alzheimer's disease. Alzheimers Res. Ther., 9, 2017, 83.
Irwin, D.J., Lee, V.M., Trojanowski, J.Q., Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies. Nat. Rev. Neurosci. 14 (2013), 626–636.
Jellinger, K.A., Interaction between pathogenic proteins in neurodegenerative disorders. J. Cell. Mol. Med. 16 (2012), 1166–1183.
Kaltenbach, L.S., Romero, E., Becklin, R.R., Chettier, R., Bell, R., Phansalkar, A., Strand, A., Torcassi, C., Savage, J., Hurlburt, A., et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet., 3, 2007, e82.
Kamath, R.S., Fraser, A.G., Dong, Y., Poulin, G., Durbin, R., Gotta, M., Kanapin, A., Le Bot, N., Moreno, S., Sohrmann, M., et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421:6920 (2003), 231–237.
Kaneda, M., Sakagami, H., Hida, Y., Ohtsuka, T., Satou, N., Ishibashi, Y., Fukuchi, M., Krysiak, A., Ishikawa, M., Ihara, D., et al. Synaptic localisation of SRF coactivators, MKL1 and MKL2, and their role in dendritic spine morphology. Sci. Rep., 8, 2018, 727.
Keiser, M.S., Kordasiewicz, H.B., McBride, J.L., Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia. Hum. Mol. Genet. 25:R1 (2016), R53–R64.
Kelley, A.R., Colley, M.E., Perry, G., Bach, S.B.H., Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and α-synuclein toward in vivo analysis. J. Mass Spectrom. 53 (2018), 162–171.
Khanam, H., Ali, A., Asif, M., Shamsuzzaman, Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review. Eur. J. Med. Chem. 124 (2016), 1121–1141.
Khurana, V., Peng, J., Chung, C.Y., Auluck, P.K., Fanning, S., Tardiff, D.F., Bartels, T., Koeva, M., Eichhorn, S.W., Benyamini, H., et al. Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways. Cell Syst. 4 (2017), 157–170.
Kirstein, J., Arnsburg, K., Scior, A., Szlachcic, A., Guilbride, D.L., Morimoto, R.I., Bukau, B., Nillegoda, N.B., In vivo properties of the disaggregase function of J-proteins and Hsc70 in Caenorhabditis elegans stress and aging. Aging Cell 16 (2017), 1414–1424.
Knöll, B., Kretz, O., Fiedler, C., Alberti, S., Schütz, G., Frotscher, M., Nordheim, A., Serum response factor controls neuronal circuit assembly in the hippocampus. Nat. Neurosci. 9 (2006), 195–204.
Krüger, L., Mandelkow, E.M., Tau neurotoxicity and rescue in animal models of human Tauopathies. Curr. Opin. Neurobiol. 36 (2016), 52–58.
Lamitina, T., Huang, C.G., Strange, K., Genome-wide RNAi screening identifies protein damage as a regulator of osmoprotective gene expression. Proc. Natl. Acad. Sci. USA 103 (2006), 12173–12178.
Liao, L., Cheng, D., Wang, J., Duong, D.M., Losik, T.G., Gearing, M., Rees, H.D., Lah, J.J., Levey, A.I., Peng, J., Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J. Biol. Chem. 279 (2004), 37061–37068.
Lim, J., Hao, T., Shaw, C., Patel, A.J., Szabó, G., Rual, J.F., Fisk, C.J., Li, N., Smolyar, A., Hill, D.E., et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125 (2006), 801–814.
Limviphuvadh, V., Tanaka, S., Goto, S., Ueda, K., Kanehisa, M., The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs). Bioinformatics 23 (2007), 2129–2138.
Ling, S.C., Polymenidou, M., Cleveland, D.W., Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79 (2013), 416–438.
Lu, T., Pan, Y., Kao, S.Y., Li, C., Kohane, I., Chan, J., Yankner, B.A., Gene regulation and DNA damage in the ageing human brain. Nature 429 (2004), 883–891.
Markovinovic, A., Cimbro, R., Ljutic, T., Kriz, J., Rogelj, B., Munitic, I., Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms. Prog. Neurobiol. 154 (2017), 1–20.
Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465 (2010), 223–226.
Mazza, A., Klockmeier, K., Wanker, E., Sharan, R., An integer programming framework for inferring disease complexes from network data. Bioinformatics 32 (2016), i271–i277.
Mizukami, K., Abrahamson, E.E., Mi, Z., Ishikawa, M., Watanabe, K., Kinoshita, S., Asada, T., Ikonomovic, M.D., Immunohistochemical analysis of ubiquilin-1 in the human hippocampus: association with neurofibrillary tangle pathology. Neuropathology 34 (2014), 11–18.
Mogk, A., Bukau, B., Role of sHsps in organizing cytosolic protein aggregation and disaggregation. Cell Stress Chaperones 22 (2017), 493–502.
Morley, J.F., Brignull, H.R., Weyers, J.J., Morimoto, R.I., The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 99 (2002), 10417–10422.
Na, D., Rouf, M., O'Kane, C.J., Rubinsztein, D.C., Gsponer, J., NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases. BMC Med. Genomics, 6, 2013, 52.
Nollen, E.A., Garcia, S.M., van Haaften, G., Kim, S., Chavez, A., Morimoto, R.I., Plasterk, R.H., Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc. Natl. Acad. Sci. USA 101 (2004), 6403–6408.
Orchard, S., Ammari, M., Aranda, B., Breuza, L., Briganti, L., Broackes-Carter, F., Campbell, N.H., Chavali, G., Chen, C., del-Toro, N., et al. The MIntAct project–IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res. 2014 Jan:42 (2014), D358–D363.
Pechmann, S., Levy, E.D., Tartaglia, G.G., Vendruscolo, M., Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins. Proc. Natl. Acad. Sci. USA 106 (2009), 10159–10164.
Pentony, M.M., Jones, D.T., Modularity of intrinsic disorder in the human proteome. Proteins 78 (2010), 212–221.
Perez-Iratxeta, C., Wjst, M., Bork, P., Andrade, M.A., G2D: a tool for mining genes associated with disease. BMC Genet., 6, 2005, 45.
Rampelt, H., Kirstein-Miles, J., Nillegoda, N.B., Chi, K., Scholz, S.R., Morimoto, R.I., Bukau, B., Metazoan Hsp70 machines use Hsp110 to power protein disaggregation. EMBO J. 31 (2012), 4221–4235.
Raychaudhuri, S., Dey, S., Bhattacharyya, N.P., Mukhopadhyay, D., The role of intrinsically unstructured proteins in neurodegenerative diseases. PLoS ONE, 4, 2009, e5566.
Ritson, G.P., Custer, S.K., Freibaum, B.D., Guinto, J.B., Geffel, D., Moore, J., Tang, W., Winton, M.J., Neumann, M., Trojanowski, J.Q., et al. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J. Neurosci. 30 (2010), 7729–7739.
Rolland, T., Taşan, M., Charloteaux, B., Pevzner, S.J., Zhong, Q., Sahni, N., Yi, S., Lemmens, I., Fontanillo, C., Mosca, R., et al. A proteome-scale map of the human interactome network. Cell 159 (2014), 1212–1226.
Rosenberg, R.N., Lambracht-Washington, D., Yu, G., Xia, W., Genomics of Alzheimer Disease: A Review. JAMA Neurol. 73 (2016), 867–874.
Rubinsztein, D.C., The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (2006), 780–786.
Ruepp, A., Waegele, B., Lechner, M., Brauner, B., Dunger-Kaltenbach, I., Fobo, G., Frishman, G., Montrone, C., Mewes, H.W., CORUM: the comprehensive resource of mammalian protein complexes—2009. Nucleic Acids Res. 38 (2010), D497–D501.
Sahni, N., Yi, S., Taipale, M., Fuxman Bass, J.I., Coulombe-Huntington, J., Yang, F., Peng, J., Weile, J., Karras, G.I., Wang, Y., et al. Widespread macromolecular interaction perturbations in human genetic disorders. Cell 161 (2015), 647–660.
Sami, N., Rahman, S., Kumar, V., Zaidi, S., Islam, A., Ali, S., Ahmad, F., Hassan, M.I., Protein aggregation, misfolding and consequential human neurodegenerative diseases. Int. J. Neurosci. 127 (2017), 1047–1057.
Scharenberg, M.A., Chiquet-Ehrismann, R., Asparuhova, M.B., Megakaryoblastic leukemia protein-1 (MKL1): Increasing evidence for an involvement in cancer progression and metastasis. Int. J. Biochem. Cell Biol. 42 (2010), 1911–1914.
Scherzinger, E., Sittler, A., Schweiger, K., Heiser, V., Lurz, R., Hasenbank, R., Bates, G.P., Lehrach, H., Wanker, E.E., Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. USA 96 (1999), 4604–4609.
Shannon, P., Markiel, A., Ozier, O., Baliga, N.S., Wang, J.T., Ramage, D., Amin, N., Schwikowski, B., Ideker, T., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 13 (2003), 2498–2504.
Shimizu, K., Toh, H., Interaction between intrinsically disordered proteins frequently occurs in a human protein-protein interaction network. J. Mol. Biol. 392 (2009), 1253–1265.
Sigoillot, F.D., King, R.W., Vigilance and validation: Keys to success in RNAi screening. ACS Chem. Biol. 6 (2011), 47–60.
Someya, A., Moss, J., Nagaoka, I., The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process. J. Biol. Chem. 285 (2010), 30698–30707.
Sreedharan, J., Blair, I.P., Tripathi, V.B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J.C., Williams, K.L., Buratti, E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 (2008), 1668–1672.
Stelzl, U., Worm, U., Lalowski, M., Haenig, C., Brembeck, F.H., Goehler, H., Stroedicke, M., Zenkner, M., Schoenherr, A., Koeppen, S., et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 122 (2005), 957–968.
Stroedicke, M., Bounab, Y., Strempel, N., Klockmeier, K., Yigit, S., Friedrich, R.P., Chaurasia, G., Li, S., Hesse, F., Riechers, S.P., et al. Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicity. Genome Res. 25 (2015), 701–713.
Suh, J., Romano, D.M., Nitschke, L., Herrick, S.P., DiMarzio, B.A., Dzhala, V., Bae, J.S., Oram, M.K., Zheng, Y., Hooli, B., et al. Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription. Cell 178 (2019), 1159–1175.
Tartaglia, G.G., Pawar, A.P., Campioni, S., Dobson, C.M., Chiti, F., Vendruscolo, M., Prediction of aggregation-prone regions in structured proteins. J. Mol. Biol. 380 (2008), 425–436.
Taylor, J.P., Brown, R.H. Jr., Cleveland, D.W., Decoding ALS: from genes to mechanism. Nature 539 (2016), 197–206.
Thomas, S., Bonchev, D., A survey of current software for network analysis in molecular biology. Hum. Genomics 4 (2010), 353–360.
Toyoshima, Y., Takahashi, H., TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis. Neuropathology 34 (2014), 77–82.
Trepte, P., Buntru, A., Klockmeier, K., Willmore, L., Arumughan, A., Secker, C., Zenkner, M., Brusendorf, L., Rau, K., Redel, A., Wanker, E.E., DULIP: A Dual Luminescence-Based Co-Immunoprecipitation Assay for Interactome Mapping in Mammalian Cells. J. Mol. Biol. 427 (2015), 3375–3388.
Trepte, P., Kruse, S., Kostova, S., Hoffmann, S., Buntru, A., Tempelmeier, A., Secker, C., Diez, L., Schulz, A., Klockmeier, K., et al. LuTHy: a double-readout bioluminescence-based two-hybrid technology for quantitative mapping of protein-protein interactions in mammalian cells. Mol. Syst. Biol., 14, 2018, e8071.
Uversky, V.N., Oldfield, C.J., Dunker, A.K., Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 37 (2008), 215–246.
Vanunu, O., Magger, O., Ruppin, E., Shlomi, T., Sharan, R., Associating genes and protein complexes with disease via network propagation. PLoS Comput. Biol., 6, 2010, e1000641.
Venkatesan, K., Rual, J.F., Vazquez, A., Stelzl, U., Lemmens, I., Hirozane-Kishikawa, T., Hao, T., Zenkner, M., Xin, X., Goh, K.I., et al. An empirical framework for binary interactome mapping. Nat. Methods 6 (2009), 83–90.
Vinayagam, A., Stelzl, U., Foulle, R., Plassmann, S., Zenkner, M., Timm, J., Assmus, H.E., Andrade-Navarro, M.A., Wanker, E.E., A directed protein interaction network for investigating intracellular signal transduction. Sci. Signal., 4, 2011, rs8.
Wang, Q., Woltjer, R.L., Cimino, P.J., Pan, C., Montine, K.S., Zhang, J., Montine, T.J., Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J. 19 (2005), 869–871.
Wanker, E.E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, J., Lehrach, H., HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. Human Molecular Genetics 6 (1997), 487–495.
Wanker, E.E., Scherzinger, E., Heiser, V., Sittler, A., Eickhoff, H., Lehrach, H., Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309 (1999), 375–386.
Wilson, A.C., Dugger, B.N., Dickson, D.W., Wang, D.S., TDP-43 in aging and Alzheimer's disease—a review. Int. J. Clin. Exp. Pathol. 4 (2011), 147–155.
Wishart, D.S., In silico drug exploration and discovery using DrugBank. Current protocols in bioinformatics, 2007 Jun(Chapter 14), 2007, Unit 14.4.
Wishart, D.S., Knox, C., Guo, A.C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z., Woolsey, J., DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34 (2006), D668–D672.
Woodsmith, J., Stelzl, U., Studying post-translational modifications with protein interaction networks. Curr. Opin. Struct. Biol. 24 (2014), 34–44.
Xia, Q., Liao, L., Cheng, D., Duong, D.M., Gearing, M., Lah, J.J., Levey, A.I., Peng, J., Proteomic identification of novel proteins associated with Lewy bodies. Front. Biosci. 13 (2008), 3850–3856.
Xu, G., Gonzales, V., Borchelt, D.R., Rapid detection of protein aggregates in the brains of Alzheimer patients and transgenic mouse models of amyloidosis. Alzheimer Dis. Assoc. Disord. 16 (2002), 191–195.
Xu, W., Tan, L., Yu, J.T., Link between the SNCA gene and parkinsonism. Neurobiol. Aging 36 (2015), 1505–1518.
Zhang, C., Browne, A., Child, D., Divito, J.R., Stevenson, J.A., Tanzi, R.E., Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-amyloid precursor protein. J. Biol. Chem. 285 (2010), 8515–8526.
